MAR 06, 2017 7:19 PM PST

Effective Cervical Cancer Screening for Underserved Populations

WRITTEN BY: Carmen Leitch

New findings about cervical cancer could be great news for women all over the world, if the findings are heeded. It seems that only a small cell sample from  women who are at high risk for developing cervical cancer would be an effective and low-cost way to make an important, early diagnosis in places considered to be low and middle income countries (LMICs). The work was led by Queen Mary University of London (QMUL) with funding from Cancer Research UK and it has been published in the Journal of Global Oncology. For women in the developing world, cervical cancer is the second most common cancer. Worldwide, it is responsible for the deaths of around a quarter of a million women every year, many of them occurring in LMICs.

A cytologic smear under the microscope / Credit: QMUL

It's a typical part of routine health screens for women that have access to health care in developed countries. However, in countries without good health care infrastructure or resources like diagnostic laboratories, there has been a glaring lack of such screening methods. Those methods, cytological or cell based processes, are usually very effective at diagnosing the threat of cervical cancer before it fully progresses to cancer.

This is the first study that examines how effective cytology is at diagnosing cervical cancer in LMICs. The investigators examined  cytology data from 23 studies in a variety of countries including fIndia, Bangladesh, China, Thailand, Kenya, South Africa, Uganda, Peru, El Salvador, Costa Rica, Nicaragua, Brazil, Argentina and Egypt, covering  717 cervical cancers. The researchers postulated that it's possible to make an earlier diagnosis of cervical cancer in these countries by employing cytology.

It was found that even in settings with limited access to resources, cytology is still very sensitive and consistent at diagnosing invasive cancer. Cytology successfully identified cancer with 95.9 percent accuracy in high-risk women that were showing symptoms.

"Cytology has long been established as an excellent screening tool to prevent cervical cancer by detecting precancerous lesions. However, little research has been carried out regarding its sensitivity to cancer," explained the corresponding author of the work, Dr. Alejandra Castanon of QMUL.

"We've found that this is an excellent tool for targeted screening of populations at high risk of cervical cancer, leading to early diagnosis. In resource-poor settings with limited facilities to treat advanced cancers, this could have a big impact on cervical cancer mortality."

Cytology could be used only on women with symptoms, and only sending those affected by severe lesions for additional treatment would result in far fewer women needing more investigation. There would subsequently be a reduction resource and cost burden, and may help catch cervical cancers at an earlier stage, thus improving the overall survival in those affected by the disease.

"The implications are that, even when a country lacks infrastructure to implement a quality-assured cervical screening program nationally, it might be able to facilitate early diagnosis of cervical cancer by using cervical cytology, and only referring women with severely abnormal smears," explained one co-author of the work, Professor Peter Sasieni from QMUL. 

If you would like more information on how improved screening for cervical cancer could help underserved, check out the webinar above, "Cervical Cancer Screening of Vulnerable Populations," in this case about people in developed nations like the US.

 

Sources: AAAS/Eurekalert! via QMUL, Journal of Global Oncology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 04, 2020
Immunology
JAN 04, 2020
Why Do Skincare Products Sometimes Cause Rashes?
Chemicals commonly found in skincare products are intended to avoid interactions with the part of the immune system resp ...
FEB 24, 2020
Clinical & Molecular DX
FEB 24, 2020
Nanoparticles provide momentum for better diagnostic imaging
Photoacoustic imaging is an emerging tool with a vast array of biomedical applications ranging from the detection of bra ...
MAR 12, 2020
Clinical & Molecular DX
MAR 12, 2020
Molecular biomarker in saliva predicts childhood obesity
Epigenetic changes modify how genes are switched on and off, without altering DNA’s genetic code sequence. These e ...
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
MAY 09, 2020
Clinical & Molecular DX
MAY 09, 2020
Rapid, Efficient COVID-19 Diagnostic Method Relies on Magnetic Beads
The pandemic virus SARS-CoV-2 has spread widely, and a lack of testing has been a serious problem.
JUN 29, 2020
Cancer
JUN 29, 2020
Mass Spectrometry and How It Can Profile Cancer
Treatments for cancer usually revolve around targeting certain immune checkpoints in the cell. Protein cell death protei ...
Loading Comments...